Member Info for douve87

Hi, just to put my two penneth in. I have no problem with Lindy being rewarded for her new role especially as she's been the driving force of scancell but I fail to see how this can perceived as sign of news imminently. Yes I suppose its good news that a PI and an II want to buy a fair quantity more but that's the only positive I can see here. I actually think this suggests we could be waiting longer than expected for the next positive news for 2 reasons 1) why would you sell shares just before an event that would increase the share price and 2) wouldn't lindy be in a close period if news (positive or negative) was about to drop. Overall its necessary business and I'm more than comfortable with it but struggling to see why some see this as a bullish announcement. Anyway as always hope I'm wrong and we have a blockbuster news tomorrow.

Good article I've not seen but my I can't help but worry we're losing our head start with the delays we've had. The article talks of modi trials in 2019, and I appreciate no one could have predicted covid but the delays/cancellations of trials here and abroad as well as cruk pulling out of scib2 are frustrating to say the least. And has been demonstrated with the most recent deadline being missed the bod seem to be incapable of meeting deadlines even ones that are vague and seemingly generous. As always the science seems amazing but I'm not convinced the bod are the necessary business nouse.

Excuse me if I'm being thick, but does anyone know why one of the trials is going to be done in South Africa (I appreciate it couldn't be done in uk at this stage due to the success of the vaccination program)? Presumably there must be a reason why SA over another country? Maybe assurances on trial approval?

19th of May 2021 according to the link. So quite recently.

Apologies if I read something out of context. Quite agree no harm in topslicing and agree that we need to start doing deals whether they are commercial or partnerships. I dont post often but you if you've seen any of my previous posts I've been getting increasingly frustrated with the bod's lack of progress. I'm a big fan of the science but have yet to be impressed by the bod's lack of commercial nouse. But I do feel (consider me a naive fool) that the corner may have
been turned. I'm not getting carried away as we're yet to have a partnership or deal but the recent publicity and announcements seem to be different to what we've seen and in the past and I hope this is redmile and vulpes input. So at I remain optimistic at present (I never publicise what my estimates are if things go well but I enjoy reading other people's calculations) but how long my goodwill remains with the bod is dependent with what happens over the next 6 months. Anyway all the best but I hope you regret selling the shares you've just sold (but by sounds you'll still do very well when the news hit we've all been waiting for).

Hasiba, respect your decision to change your mind. As others have said its your money and you can do what you like with it. But I feel its unnecessary to tell others who are still optimistic about scancells prospects to get real and to say they're never get rich from scancell. I also find your total 180 from buying at every opportunity to trying to get out as soon as possible a little surprising. Lastly I find it strange that youre seemingly surprised you can't sell your entire scancell holding of millions in one go.
With someone with your investment strategies and experience surely you realised when you bought millions of shares it wouldn't be as easy as getting rid of a small biotech on aim as tesco and the like. Anyway I genuinely wish you well and respect your investment decisions even if I don't currently agree (but you could be proven right who know). All the best.

Could be an interesting week? Not trying to be negative but could it just be a general presentation brought about in recognition of the recent publicity and the benefit of the new shareholders?

If there was to be an rns with market sensitive info to be released in the next couple of days wouldnt Diggle have been in a closed period and unable to have sold?

Sorry I dont understand what you are saying? 'Looks like we may not be looking up with these two?' Apologies if I'm being dim.

Hi, I'm sure il be corrected if I'm wrong but I don't think they've ever disclosed how long they intend to hold for (I'd be surprised if they ever do). I believe from past investments they don't hold long term but scancell could be different. I'd expect them to be here for at least 2-3 years as that's when we should have some results by (hopefully outstanding ones) in which case they may look to extract value at that point but this is all pure guess work.

Balerno you said hopefully cruk can be bought out but to my knowledge they've done absolutely nothing with scib2 to date so there should be no buying back. All they've done is delay its progress for 2 years so can't really see why they should receive any funds. Its true they had certain rights if they had done the testing but as that's not been done surely they've acquired no rights?

Hi Chelsea, hope you are keeping well.

How do you know the recording was done before they needed our yes vote? I haven't listened to since Monday but I'm fairly sure it starts by thanking shareholders for supporting both oo? So that would be after they needed our votes?

Btw I'm still positive that a commercial deal will be done at some point due to the science we are working on (and has many people have said only one platform has to work to give us all a good profit) but the timeline being kept is now crucial and the presentation hardly filled me with confidence that it will be kept. I just worry that the bod see this as merely some sort of uni research project. They need to start acting like a biotech company/pharma and think of the pi (not just when they need a vote passing).

Knowlesi, you say and judging by the timelines shared on Monday I agree a commercial deal seems far off now. But my question remains why? I know I must sound like a broken record but why has CH kept talking about commercial deals and even said one likely to conclude within the next 2 months and then not conclude one and give a timeline like the one given on Monday which sounds like we're nowhere near? Again apologies to repeat myself but still very disappointed by the bods business nouse. Also no update or mention of the collaborations? Why? I know they can't (or shouldn't say a deal imminent) but could say still ongoing, promising work so far, ceased, or delayed due to covid. To say nothing along with that timeline goes someway to explain the shareprice reaction in my opinion but it has been overdone as too as the reaction to Pfizer news (we were never competing with Pfizer we were always aiming to be 2nd gen).

Should say "would show vulpes were right to object"

Dont get me wrong i want the shareprice higher as does any investor (equally want the science to be validated and to help suffering patients). But I'm conflicted as I would be seething if there was significance news tomorrow as its comes back to what we've all been been asking why raise further funds now. If was news tomorrow or this week would should vulpes were right to object as we've been dilluted a hell of lot more than necessary. Completely agree with Chester what we need this week is answers as to why funding was so crucial now and why it couldn't wait until further data came in?

Am I right that we will get a recorded report by close of play on Monday? Or was that pushed back when the GM was adjourned?

No, they said significantly over subscribed last week as well.

Not delivered so maybe its time we held the bod accountable instead of blaming vulpes.

Ruck 21.58 message. Couldn't agree more better to focus on one or two trials and complete them rather then half completing loads of trials. I have voted and am supporting the bod but it was a close thing. The bod need to do better and need to actually start sticking to their plans, timelines and completing commercial deals. I still have fears that they are great research scientists but terrible business men.

I would normally agree that having all those funds would be a great thing and definitely would have a year ago. But alot has changed in the last year except for commercial deals. From what we know that additional finance wasn't required now as the balance sheet has never looked healthier (before this oo); even without a commercial deal that has clearly been kicked into the long grass it wasn't necessary now. And if a deal is near then even more reason not to raise more now. I am extremely frustrated that the bod have changed their plans again and pushed commercial deals back again. When CH talked of a commercial deal in the next two months the way he was talking discussions must have been advanced otherwise why give such a tight timeline. And if they were advanced he would surely have had an idea of figures and if the figures weren't sufficient then why state a deal within 2 months? So either he had a terrible deal but was pursuing it regardless in which case poor business nouse or he had a good deal that has fallen through again (poor business nouse). I know people will say better data better deals but we've been saying that for 8 years and we have great data (and other biotechs with lesser data have secured good deals). I fear the new enlarged team are becoming too comfortable thinking of scancell as purely a research enterprise when its meant to be a business. But like I say I have supported the bod again on this occasion so hopefully they will come good finally.

Lastly from what I've read I cant see any reason why vulpes will have to sell up, nothing ive read suggests that relationship is irreparably damaged but admittedly everything ive read has been pure speculation? 1st as I asked earlier have we had any confirmation it was vulpes who voted against because they could have converted to have more shares to vote for the motion? 2nd if we believe nxt (or whatever his name is on adfvn) and it was vulpes that voted against it was stated that it was over the terms of the finance not the finance itself so i don't understand why people are saying vulpes wanted to keep price down and dillute further? 3rd i read vulpes have taken up their oo shares which again doesn't seem like the actions of a company thats about to sell up. As mentioned in previous posts I along with everyone else on this forum don't know whats going on and thats part of the problem but I don't think it good to be making vulpes look like the villains when we know so little about whats got on. We know a lot more about what the bod have stated (such as CH) and then not